Loading...

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial

BACKGROUND: The need for low toxicity adjuncts to standard care chemotherapy in inoperable colorectal cancer, with potential to improve outcomes and decrease the side-effect burden, is well recognised. Addition of the low toxicity diet-derived agent, curcumin (the active ingredient of turmeric), to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Trials
Main Authors: Irving, Glen RB, Iwuji, Chinenye OO, Morgan, Bruno, Berry, David P, Steward, William P, Thomas, Anne, Brown, Karen, Howells, Lynne M
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4392790/
https://ncbi.nlm.nih.gov/pubmed/25872567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-015-0641-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!